Categories AlphaGraphs, Earnings, Technology

AMD Q2 2025 adj. earnings drop, despite strong revenue growth

Advanced Micro Devices, Inc. (NASDAQ: AMD) reported a decline in adjusted earnings for the second quarter of fiscal 2025, when its revenues increased sharply year-over-year. The top line also exceeded estimates.

The chipmaker’s earnings, on an adjusted basis, were $0.48 per share in the second quarter, compared to $0.69 per share in the same period of 2024. On a reported basis, net income came in at $872 million or $0.54 per share in Q2, compared to $265 million or $0.16 per share in the prior-year period.

AMD Q2 2025 Earnings

The company reported revenues of $7.7 billion for the June quarter, vs. $5.83 billion in the comparable period in the prior year. Earnings matched estimates while revenues exceeded expectations.

Lisa Su, AMD’s CEO, said, “We are seeing robust demand across our computing and AI product portfolio, and are well positioned to deliver significant growth in the second half of the year, driven by the ramp of our AMD Instinct MI350 series accelerators and ongoing EPYC and Ryzen processor share gains.”

Prior Performance

  • AMD Q1 2025 earnings infographic
  • AMD Q4 2024 earnings infographic
  • AMD Q2 2024 earnings infographic
  • AMD Q1 2024 earnings infographic

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

Citigroup set to report Q4 2025 earnings. Here’s what to expect

Citigroup Inc. (NYSE: C) has undergone a sweeping transformation in recent years, emerging as a more streamlined and profitable financial institution. The bank's performance in recent quarters has underscored the

Home Depot (HD), Lowe’s (LOW): Home improvement pressures not expected to abate soon

Home improvement retailers Home Depot (NYSE: HD) and Lowe’s Companies, Inc. (NYSE: LOW) have been facing a challenging operating environment for a while now. The companies have been battling macroeconomic

Earnings Summary: AngioDynamics (ANGO) Q2 FY26 sales increase 8.8%

Medical technology company AngioDynamics, Inc. (NASDAQ: ANGO) on Tuesday reported an increase in net sales for the second quarter of fiscal 2026. In Q2, net sales increased 8.8% year-over-year to

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top